(Q39144404)

9 September 2017

title

Plasma concentrations, bioavailability and dissolution of chlorpropamide (English)

1 reference

17 March 2022

1 reference

17 March 2022

1 reference

T. Taylor

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A15845

17 March 2022

D. F. Assinder

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A15845

17 March 2022

L. F. Chasseaud

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A15845

17 March 2022

P. M. Bradford

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A15845

17 March 2022

J. S. Burton

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A15845

17 March 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15845

17 March 2022

publication date

1 March 1977

1 reference

9 September 2017

11 March 1977

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15845

full work available at URL

17 March 2022

http://link.springer.com/content/pdf/10.1007/BF00606412.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF00606412/fulltext.html

17 March 2022

1 reference

http://link.springer.com/content/pdf/10.1007/BF00606412

17 March 2022

1 reference

European Journal of Clinical Pharmacology

17 March 2022

published in

1 reference

9 September 2017

volume

11

1 reference

9 September 2017

issue

3

1 reference

9 September 2017

page(s)

207-212

1 reference

A COMPARATIVE STUDY OF SOME BRANDS OF TOLBUTAMIDE AVAILABLE IN CANADA. II. PHARMACEUTICAL ASPECTS

9 September 2017

cites work

1 reference

12 December 2020

Use of confidence intervals in analysis of comparative bioavailability trials.

1 reference

12 December 2020

Generic Inequivalence - Clinical Observations

1 reference

12 December 2020

Status report on drug bio-availability

1 reference

12 December 2020

Bioavailability--a problem in equivalence.

1 reference

12 December 2020

Automated dissolution test for tablets and capsules

1 reference

12 December 2020

Substitution for Brand-Named Drugs

1 reference

12 December 2020

Pharmacokinetics and biotransformation of chlorpropamide in man

1 reference

12 December 2020

The bioavailability in man of marketed brands of chlorpropamide

1 reference

12 December 2020

Diabetes mellitus: the thin maturity-onset diabetic

1 reference

12 December 2020

Gas-liquid chromatographic estimation of tolbutamide and chlorpropamide in plasma

1 reference

12 December 2020

Method of estimating relative absorption of a drug in a series of clinical studies in which blood levels are measured after single and/or multiple doses

1 reference

12 December 2020

The generic inequivalence of drugs

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00606412

1 reference

9 September 2017

1 reference